Leukemia: Beyond Chemotherapy

It's hard not to get excited about an experimental cancer drug that shows real promise fighting chronic myeloid leukemia. The standard treatments for this rare disease--chemotherapy and interferon--are pretty tough on the body. Bone-marrow transplants can lead to a cure, but even patients with a perfectly matched donor face a 20% risk of dying in the first six months after the procedure.

So there was plenty to celebrate last week when the first articles on a new drug called Glivec appeared in the New England Journal of Medicine. They reported that the drug kills leukemia cells (and only leukemia cells)...

Want the full story?

Subscribe Now


Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!